Be aware of the relationship between pain and negative adaptive behaviors, especially in teenagers.
FDA Approves Voclosporin Label Update in Lupus Nephritis to Reflect Long-Term Data
Emerging Agents in the Treatment of Rheumatic Diseases
Secukinumab 300 mg May Improve PsA or Active Psoriasis More Than 150 mg
Challenges with Step Therapy Protocols in Treating Rheumatoid Arthritis
FDA Grants Nipocalimab Fast Track Designation for Rare Fetal Disease, with Katie Abouzahr, MD
International Working Group Releases First Guideline for Osteoporosis in Men